Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 20 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Glucagon-like peptides 1 and 2 in health and disease: A reviewMarathe, C.; Rayner, C.; Jones, K.; Horowitz, M.
2014Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetesMarathe, C.; Rayner, C.; Bound, M.; Checklin, H.; Standfield, S.; Wishart, J.; Lange, K.; Jones, K.; Horowitz, M.
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2015Relationships of early and late glycemic responses with gastric emptying during an oral glucose tolerance testMarathe, C.; Horowitz, M.; Trahair, L.; Wishart, J.; Bound, M.; Lange, K.; Rayner, C.; Jones, K.
2015Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?Wu, T.; Trahair, L.; Bound, M.; Deacon, C.; Horowitz, M.; Rayner, C.; Jones, K.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.
2013Mechanisms and clinical efficacy of lixisenatide for the management of type 2 DiabetesHorowitz, M.; Rayner, C.; Jones, K.
2013Prognosis of diabetic gastroparesisa 25-year evaluationChang, J.; Rayner, C.; Jones, K.; Horowitz, M.
2016Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetesWu, T.; Zhang, X.; Trahair, L.; Bound, M.; Little, T.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.